Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liyanage, M.
Right arrow Articles by Ried, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liyanage, M.
Right arrow Articles by Ried, T.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 September 2000, Vol. 96, No. 5, pp. 1940-1946

NEOPLASIA

Abnormal rearrangement within the alpha /delta T-cell receptor locus in lymphomas from Atm-deficient mice

Marek Liyanage, Zoë Weaver, Carrolee Barlow, Allen Coleman, Daniel G. Pankratz, Stacie Anderson, Anthony Wynshaw-Boris, and Thomas Ried

From the Genome Technology Branch and Genetic Disease Research Branch, National Human Genome Research Institute; and the Genetics Department, Division of Clinical Sciences, National Institutes of Health, Bethesda, MD.

Atm-deficient mice (Atm-/-) recapitulate many aspects of the ataxia telangiectasia (AT) syndrome, including the susceptibility to tumors of lymphoid origin. To investigate the mechanism of tumorigenesis, we have examined a panel of 8 thymic lymphomas from Atm-/- mice. All Atm-/- tumors are of thymic lymphoblastoid origin, display an immature CD3- and CD4+/CD8+ phenotype, and arise coincident with V(D)J recombination. Cytogenetically, all tumors are diploid or near diploid but exhibit multiple chromosome aberrations with an average of 4 abnormal chromosomes per tumor. All the tumors revealed chromosome 14 rearrangements precisely at the T-cell receptoralpha /delta (Tcralpha /delta ) locus, suggesting the involvement of V(D)J recombination in these translocations. In addition, 11.5% of Atm-/- peripheral T cells showed chromosome 14 translocations, suggesting that rearrangements at the Tcralpha /delta locus occur early during tumor development in the absence of ATM. However, additional genetic aberrations are required for tumorigenesis. For example, translocations involving chromosome 12, often with chromosome 14 (more than 60%), and partial or complete trisomy of chromosome 15, with copy number increases of the c-myc oncogene were frequently observed. These observations suggest that ATM is required for normal rearrangement of the Tcralpha /delta locus but not for V(D)J recombination at other loci. The mechanisms that lead to tumorigenesis may be due to the involvement of ATM in monitoring double-stranded DNA breaks.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JEMHome page
B. Yin, V. Savic, M. M. Juntilla, A. L. Bredemeyer, K. S. Yang-Iott, B. A. Helmink, G. A. Koretzky, B. P. Sleckman, and C. H. Bassing
Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination
J. Exp. Med., November 11, 2009; (2009) jem.20091320v3.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. K. Mahowald, J. M. Baron, M. A. Mahowald, S. Kulkarni, A. L. Bredemeyer, C. H. Bassing, and B. P. Sleckman
Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis
PNAS, October 27, 2009; 106(43): 18339 - 18344.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Reimann, C. Loddenkemper, C. Rudolph, I. Schildhauer, B. Teichmann, H. Stein, B. Schlegelberger, B. Dorken, and C. A. Schmitt
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Blood, October 15, 2007; 110(8): 2996 - 3004.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. Dorsett, D. F. Robbiani, M. Jankovic, B. Reina-San-Martin, T. R. Eisenreich, and M. C. Nussenzweig
A role for AID in chromosome translocations between c-myc and the IgH variable region
J. Exp. Med., September 3, 2007; 204(9): 2225 - 2232.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. H. Maclean, M. B. Kastan, and J. L. Cleveland
Atm Deficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis
Mol. Cancer Res., July 1, 2007; 5(7): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
M. F. Lavin, N. Gueven, S. Bottle, and R. A. Gatti
Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia
Br. Med. Bull., June 23, 2007; (2007) ldm012v1.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-Y. Huang, G. G. Sharma, L. M. Walker, C. H. Bassing, T. K. Pandita, and B. P. Sleckman
Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes
J. Exp. Med., June 11, 2007; 204(6): 1371 - 1381.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. S. Vacchio, A. Olaru, F. Livak, and R. J. Hodes
ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor {alpha} locus coding end breaks
PNAS, April 10, 2007; 104(15): 6323 - 6328.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. R. Matei, R. A. Gladdy, L. M. J. Nutter, A. Canty, C. J. Guidos, and J. S. Danska
ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes
Blood, March 1, 2007; 109(5): 1887 - 1896.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Ito, K. Takubo, F. Arai, H. Satoh, S. Matsuoka, M. Ohmura, K. Naka, M. Azuma, K. Miyamoto, K. Hosokawa, et al.
Regulation of Reactive Oxygen Species by Atm Is Essential for Proper Response to DNA Double-Strand Breaks in Lymphocytes
J. Immunol., January 1, 2007; 178(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Reliene and R. H. Schiestl
Antioxidants Suppress Lymphoma and Increase Longevity in Atm-Deficient Mice
J. Nutr., January 1, 2007; 137(1): 229S - 232S.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. V. Pusapati, R. J. Rounbehler, S. Hong, J. T. Powers, M. Yan, K. Kiguchi, M. J. McArthur, P. K. Wong, and D. G. Johnson
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
PNAS, January 31, 2006; 103(5): 1446 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T.J. Bowen, H. Yakushiji, C. Montagna, S. Jain, T. Ried, and A. Wynshaw-Boris
Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching
Cancer Res., October 1, 2005; 65(19): 8736 - 8746.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. J. Winrow, D. G. Pankratz, C. R. T. Vibat, T.J. Bowen, M. A. Callahan, A. J. Warren, B. S. Hilbush, A. Wynshaw-Boris, K. W. Hasel, Z. Weaver, et al.
Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas
Hum. Mol. Genet., September 15, 2005; 14(18): 2671 - 2684.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor
Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. M. Lumsden, T. McCarty, L. K. Petiniot, R. Shen, C. Barlow, T. A. Wynn, H. C. Morse III, P. J. Gearhart, A. Wynshaw-Boris, E. E. Max, et al.
Immunoglobulin Class Switch Recombination Is Impaired in Atm-deficient Mice
J. Exp. Med., November 1, 2004; 200(9): 1111 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Marinkovic, T. Marinkovic, E. Kokai, T. Barth, P. Moller, and T. Wirth
Identification of novel Myc target genes with a potential role in lymphomagenesis
Nucleic Acids Res., October 11, 2004; 32(18): 5368 - 5378.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Schubert, L. Erker, C. Barlow, H. Yakushiji, D. Larson, A. Russo, J. B. Mitchell, and A. Wynshaw-Boris
Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice
Hum. Mol. Genet., August 15, 2004; 13(16): 1793 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Qi, M. A. Strong, B. O. Karim, M. Armanios, D. L. Huso, and C. W. Greider
Short Telomeres and Ataxia-Telangiectasia Mutated Deficiency Cooperatively Increase Telomere Dysfunction and Suppress Tumorigenesis
Cancer Res., December 1, 2003; 63(23): 8188 - 8196.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Pan-Hammarstrom, S. Dai, Y. Zhao, I. F. van Dijk-Hard, R. A. Gatti, A.-L. Borresen-Dale, and L. Hammarstrom
ATM Is Not Required in Somatic Hypermutation of VH, but Is Involved in the Introduction of Mutations in the Switch {micro} Region
J. Immunol., April 1, 2003; 170(7): 3707 - 3716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Yan, X. Kuang, W. Qiang, J. Shen, K. Claypool, W. S. Lynn, and P. K. Y. Wong
Prevention of Thymic Lymphoma Development in Atm-/- Mice by Dexamethasone
Cancer Res., September 15, 2002; 62(18): 5153 - 5157.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. J. Difilippantonio, S. Petersen, H. T. Chen, R. Johnson, M. Jasin, R. Kanaar, T. Ried, and A. Nussenzweig
Evidence for Replicative Repair of DNA Double-Strand Breaks Leading to Oncogenic Translocation and Gene Amplification
J. Exp. Med., August 19, 2002; 196(4): 469 - 480.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. K. Petiniot, Z. Weaver, M. Vacchio, R. Shen, D. Wangsa, C. Barlow, M. Eckhaus, S. M. Steinberg, A. Wynshaw-Boris, T. Ried, et al.
RAG-Mediated V(D)J Recombination Is Not Essential for Tumorigenesis in Atm-Deficient Mice
Mol. Cell. Biol., May 1, 2002; 22(9): 3174 - 3177.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. J. Perkins, A. Nair, D. O. Cowley, T. Van Dyke, Y. Chang, and D. A. Ramsden
Sensing of intermediates in V(D)J recombination by ATM
Genes & Dev., January 15, 2002; 16(2): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Stankovic, G. S. Stewart, C. Fegan, P. Biggs, J. Last, P. J. Byrd, R. D. Keenan, P. A. H. Moss, and A. M. R. Taylor
Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage
Blood, January 1, 2002; 99(1): 300 - 309.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. YAN, W. QIANG, N. LIU, J. SHEN, W. S. LYNN, and P. K. Y. WONG
The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes
FASEB J, May 1, 2001; 15(7): 1132 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Resor, T. J. Bowen, and A. Wynshaw-Boris
Unraveling human cancer in the mouse: recent refinements to modeling and analysis
Hum. Mol. Genet., April 1, 2001; 10(7): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. M. Allen, H. van Praag, J. Ray, Z. Weaver, C. J. Winrow, T. A. Carter, R. Braquet, E. Harrington, T. Ried, K. D. Brown, et al.
Ataxia telangiectasia mutated is essential during adult neurogenesis
Genes & Dev., March 1, 2001; 15(5): 554 - 566.
[Abstract] [Full Text]


Home page
ScienceHome page
H. T. Chen, A. Bhandoola, M. J. Difilippantonio, J. Zhu, M. J. Brown, X. Tai, E. P. Rogakou, T. M. Brotz, W. M. Bonner, T. Ried, et al.
Response to RAG-Mediated V(D)J Cleavage by NBS1 and {gamma}-H2AX
Science, December 8, 2000; 290(5498): 1962 - 1964.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020